News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
360,105 Results
Type
Article (23241)
Company Profile (141)
Press Release (336723)
Multimedia
Podcasts (74)
Webinars (11)
Section
Business (111213)
Career Advice (932)
Deals (19301)
Drug Delivery (99)
Drug Development (54631)
Employer Resources (85)
FDA (8133)
Job Trends (8128)
News (196725)
Policy (18373)
Tag
Academia (996)
Academic (1)
Accelerated approval (4)
Adcomms (17)
Allergies (45)
Alliances (29599)
ALS (61)
Alzheimer's disease (685)
Antibody-drug conjugate (ADC) (97)
Approvals (8147)
Artificial intelligence (148)
Autoimmune disease (17)
Automation (8)
Bankruptcy (182)
Best Places to Work (5859)
BIOSECURE Act (13)
Biosimilars (100)
Biotechnology (67)
Bladder cancer (45)
Brain cancer (19)
Breast cancer (125)
Cancer (1229)
Cardiovascular disease (124)
Career advice (755)
Career pathing (21)
CAR-T (80)
Cell therapy (254)
Cervical cancer (5)
Clinical research (45562)
Collaboration (521)
Compensation (201)
Complete response letters (24)
COVID-19 (1161)
CRISPR (27)
C-suite (165)
Cystic fibrosis (61)
Data (1312)
Decentralized trials (2)
Denatured (18)
Depression (26)
Diabetes (163)
Diagnostics (1904)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (24)
Drug discovery (91)
Drug pricing (113)
Drug shortages (31)
Duchenne muscular dystrophy (63)
Earnings (41178)
Editorial (32)
Employer branding (11)
Employer resources (79)
Events (52953)
Executive appointments (487)
FDA (8820)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (365)
Gene editing (62)
Generative AI (18)
Gene therapy (170)
GLP-1 (611)
Government (1997)
Grass and pollen (3)
Guidances (32)
Healthcare (6657)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (92)
Indications (19)
Infectious disease (1248)
Inflammatory bowel disease (90)
Inflation Reduction Act (8)
Influenza (26)
Intellectual property (64)
Interviews (125)
IPO (7750)
IRA (45)
Job creations (2532)
Job search strategy (686)
Kidney cancer (8)
Labor market (25)
Layoffs (292)
Leadership (16)
Legal (4331)
Liver cancer (34)
Lung cancer (180)
Lymphoma (107)
Machine learning (3)
Management (31)
Manufacturing (230)
MASH (52)
Medical device (2253)
Medtech (2256)
Mergers & acquisitions (11838)
Metabolic disorders (533)
Multiple sclerosis (53)
NASH (20)
Neurodegenerative disease (53)
Neuropsychiatric disorders (23)
Neuroscience (1037)
NextGen: Class of 2025 (2622)
Non-profit (1161)
Now hiring (23)
Obesity (326)
Opinion (217)
Ovarian cancer (40)
Pain (73)
Pancreatic cancer (40)
Parkinson's disease (96)
Partnered (11)
Patents (166)
Patient recruitment (53)
Peanut (16)
People (35177)
Pharmaceutical (76)
Pharmacy benefit managers (21)
Phase I (14609)
Phase II (19468)
Phase III (15183)
Pipeline (825)
Policy (131)
Postmarket research (1672)
Preclinical (5367)
Press Release (30)
Prostate cancer (65)
Psychedelics (16)
Radiopharmaceuticals (164)
Rare diseases (276)
Real estate (3380)
Recruiting (30)
Regulatory (13329)
Reports (24)
Research institute (1045)
Resumes & cover letters (145)
Rett syndrome (1)
RNA editing (2)
RSV (25)
Schizophrenia (62)
Series A (65)
Series B (35)
Service/supplier (7)
Sickle cell disease (48)
Special edition (15)
Spinal muscular atrophy (114)
Sponsored (15)
Startups (2160)
State (2)
Stomach cancer (9)
Supply chain (56)
Tariffs (44)
The Weekly (54)
Vaccines (294)
Venture capitalists (30)
Weight loss (245)
Women's health (15)
Worklife (8)
Date
Today (65)
Last 7 days (471)
Last 30 days (1397)
Last 365 days (17991)
2025 (5992)
2024 (19042)
2023 (21217)
2022 (27735)
2021 (28561)
2020 (26543)
2019 (21529)
2018 (16823)
2017 (18358)
2016 (17294)
2015 (20260)
2014 (15950)
2013 (13750)
2012 (14742)
2011 (14968)
2010 (13763)
Location
Africa (445)
Alabama (23)
Alaska (2)
Arizona (80)
Arkansas (8)
Asia (26747)
Australia (3739)
California (2947)
Canada (1205)
China (357)
Colorado (108)
Connecticut (116)
Delaware (87)
Europe (54437)
Florida (525)
Georgia (71)
Idaho (25)
Illinois (269)
India (20)
Indiana (184)
Iowa (3)
Japan (130)
Kansas (67)
Kentucky (19)
Louisiana (2)
Maine (4)
Maryland (406)
Massachusetts (2387)
Michigan (51)
Minnesota (150)
Mississippi (1)
Missouri (29)
Montana (13)
Nebraska (11)
Nevada (23)
New Hampshire (8)
New Jersey (1126)
New Mexico (22)
New York (859)
North Carolina (554)
North Dakota (2)
Northern California (1249)
Ohio (91)
Oklahoma (5)
Oregon (23)
Pennsylvania (678)
Puerto Rico (12)
Rhode Island (18)
South America (670)
South Carolina (3)
Southern California (1217)
Tennessee (39)
Texas (365)
United States (11551)
Utah (60)
Virginia (95)
Washington D.C. (46)
Washington State (323)
Wisconsin (23)
360,105 Results for "stem pharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharming Group to report first quarter 2025 financial results on May 8
April 24, 2025
·
1 min read
Press Releases
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
April 23, 2025
·
8 min read
Press Releases
Pharming Group to participate in April 2024 investor conferences
March 28, 2025
·
1 min read
Business
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
Stem Pharm, Inc. and Verge Genomics, announced a collaboration to develop a disease model to validate novel targets identified by Verge for Parkinson’s disease (PD).
October 10, 2023
·
3 min read
Press Releases
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
April 28, 2025
·
5 min read
Press Releases
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
May 1, 2025
·
3 min read
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
Pharming Group to participate in June 2024 investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.
June 3, 2024
·
1 min read
Press Releases
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
March 13, 2025
·
40 min read
Press Releases
Pharming Group to participate in February 2025 investor conference
February 10, 2025
·
1 min read
1 of 36,011
Next
